News
Soon-to-be medical student awarded $10K after spotting melanoma
“The mole on the back of your neck is possibly cancerous. Please go see a doctor!”
News
FDA approves time-saving combo for r/r multiple myeloma
“The approval will help clinicians address unmet patient needs by reducing the administration time from hours to just minutes and reducing the...
News
What’s hot at the world’s premiere breast cancer meeting
An important study of an investigational oral agent for postmenopausal women who have been treated for ER positive advanced breast cancer...
News
After doc uproar, NCCN reverses prostate cancer guidance
This advice aligns closely with the group’s initial recommendation, published over a decade ago.
News
FDA approves imaging drug for detecting ovarian cancer lesions
Drug inventor Philip Low, PhD, said the agent causes ovarian cancer lesions to “light up like stars against a night sky.”
News
EU panel endorses first-of-its-kind lung cancer drug
Sotorasib is an inhibitor of KRAS G12C, an oncogenic driver of tumorigenesis.
News
Shock, disbelief as NCCN changes prostate cancer guidance
“To suggest for a millisecond that active surveillance isn’t the preferred method for low-risk men is bizarre thinking ... Is this 1980?”
News
NCI mammography trial mostly a ‘waste,’ says expert
Harvard physician says TMIST is underpowered and as a result, may be misleading.
News
Does eating nuts lead to better breast cancer outcomes?
A little may go a long way, as research to date “suggests only small amounts may be needed to gain potential benefits.”
News
FDA approves first CAR T-cell for adult ALL: For patients with R/R B-cell disease
“This is a meaningful advance because roughly half of all adults with B-ALL will relapse on currently available therapies.”
News
‘Beloved’ fired oncologist inspires patient-funded billboards
“This is something of a phenomenon — this doctor is so beloved in this community. We will not give up.”
News
Call for a move or boycott of big Texas cancer meeting
“I think that if Texas officials understood that when they pass laws inhospitable to women, we will not hold a major conference about women’s...
News
Patients panic as docs cut off breast cancer drug
Experts say discontinuing atezolizumab is not advised if a patient is responding or is stable.
News
Flurry of cancer drug endorsements from EU panel
Approvals include pralsetinib for non-small cell lung cancer, ripretinib for advanced gastrointestinal stromal tumor, and zanubrutinib for...
News
FDA approves first oral drug for NSCLC with EGFR Exon 20 insertion
Mobocertinib is the first oral tyrosine kinase inhibitor for patients with metastatic non–small cell lung cancer who have an EGFR Exon 20...